PRESS RELEASE, 10 October 2021: 

P4 Precision Medicine Accelerator announces the launch of P4SY, a programme supporting up to 50 companies in the South Yorkshire region focusing on bringing UK health and medtech companies to market, and promoting them to achieve key milestones in order to reach investment. 

P4, in partnership with Nuffield Health and Barclays Eagle Labs, is a strongly established and successful accelerator programme which supports leading precision medicine startups. P4 aids development and scale of companies across the UK and internationally. P4 supports startups based on ‘the four Ps’: predictive, preventative, participatory and precision. 

About P4SY:

The P4SY accelerator programme is part of the TEAM SY project, led by Capital Enterprise and Barnsley Council. TEAM SY is part funded by the ERDF, and is supported by Northern Powerhouse and the Olympic Legacy Park. P4SY is a new programme, launching in January 2022, created to support and scale health and medtech companies in South Yorkshire. Over three months, P4SY will host sessions to support startups and encourage their engagement with the NHS and regional local health systems. Participants will additionally gain an expert mentor to help them build a network and develop collaborations and partnerships in the region and beyond. 

Participants will have the opportunity to connect with the P4 network, a combination of previous cohort members and decision makers as well as industry partners. Notable alumni of the P4 programme include Motilent and LifeBit, who recently secured a $60mil raise with TigerGlobal. 


For more information, take a look at P4SY: P4 Precision Medicine Accelerator | Advancing Precision Medicine, where applications are now live.